Delta-like ligand 3 (DLL3) is a highly relevant target for radiopharmaceutical therapy due to its expression in more than 85% of tumors of patients with small-cell lung cancer. MP-0712 is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback